India, as a predominantly agrarian economy, faces significant challenges in agriculture, including substantial crop losses caused by diseases, pests, and environmental stress. Early detection and accurate identification of diseases across different crops are critical for improving yield and ensuring food security. This paper proposes a deep learning based solution for detecting multiple diseases in multiple crops, aimed to cover India's diverse agricultural landscape. We first create a unified dataset encompassing images of 17 different crops and 34 different diseases from various available repositories. Proposed deep learning model is trained on this dataset and outperforms the state-of-the-art in terms of accuracy and the number of crops, diseases covered. We achieve a significant detection accuracy, i.e., 99 percent for our unified dataset which is 7 percent more when compared to state-of-the-art handling 14 crops and 26 different diseases only. By improving the number of crops and types of diseases that can be detected, proposed solution aims to provide a better product for Indian farmers.
Comorbidity networks, which capture disease-disease co-occurrence usually based on electronic health records, reveal structured patterns in how diseases cluster and progress across individuals. However, how these networks evolve across different age groups and how this evolution relates to properties like disease prevalence and mortality remains understudied. To address these issues, we used publicly available comorbidity networks extracted from a comprehensive dataset of 45 million Austrian hospital stays from 1997 to 2014, covering 8.9 million patients. These networks grow and become denser with age. We identified groups of diseases that exhibit similar patterns of structural centrality throughout the lifespan, revealing three dominant age-related components with peaks in early childhood, midlife, and late life. To uncover the drivers of this structural change, we examined the relationship between prevalence and degree. This allowed us to identify conditions that were disproportionately connected to other diseases. Using betweenness centrality in combination with mortality data, we further identified high-mortality bridging diseases. Several diseases show high connectivity relati
Univariate zero-inflated models are increasingly being used to account for excess zeros in spatio-temporal infectious disease counts. However, the multivariate case is challenging due to the need to account for correlations across space, time and disease in both the count and zero-inflated components of the model. We are interested in comparing the transmission dynamics of several co-circulating infectious diseases across space and time, where some of the diseases can be absent for long periods. We first assume there is a baseline disease that is well-established and always present in the region. The other diseases switch between periods of presence and absence in each area through a series of coupled Markov chains, which account for long periods of disease absence, disease interactions and disease spread from neighboring areas. Since we are mainly interested in comparing the diseases, we assume the cases of the present diseases in an area jointly follow an autoregressive multinomial model. We use the multinomial model to investigate whether there are associations between certain factors, such as temperature, and differences in the transmission intensity of the diseases. Inference
Generalist Large Language Models (LLMs), such as GPT-4, have shown considerable promise in various domains, including medical diagnosis. Rare diseases, affecting approximately 300 million people worldwide, often have unsatisfactory clinical diagnosis rates primarily due to a lack of experienced physicians and the complexity of differentiating among many rare diseases. In this context, recent news such as "ChatGPT correctly diagnosed a 4-year-old's rare disease after 17 doctors failed" underscore LLMs' potential, yet underexplored, role in clinically diagnosing rare diseases. To bridge this research gap, we introduce RareBench, a pioneering benchmark designed to systematically evaluate the capabilities of LLMs on 4 critical dimensions within the realm of rare diseases. Meanwhile, we have compiled the largest open-source dataset on rare disease patients, establishing a benchmark for future studies in this domain. To facilitate differential diagnosis of rare diseases, we develop a dynamic few-shot prompt methodology, leveraging a comprehensive rare disease knowledge graph synthesized from multiple knowledge bases, significantly enhancing LLMs' diagnostic performance. Moreover, we pres
The recent increase in morbidity is primarily due to chronic diseases including Diabetes, Heart disease, Lung cancer, and brain tumours. The results for patients can be improved, and the financial burden on the healthcare system can be lessened, through the early detection and prevention of certain disorders. In this study, we built a machine-learning model for predicting the existence of numerous diseases utilising datasets from various sources, including Kaggle, Dataworld, and the UCI repository, that are relevant to each of the diseases we intended to predict. Following the acquisition of the datasets, we used feature engineering to extract pertinent features from the information, after which the model was trained on a training set and improved using a validation set. A test set was then used to assess the correctness of the final model. We provide an easy-to-use interface where users may enter the parameters for the selected ailment. Once the right model has been run, it will indicate whether the user has a certain ailment and offer suggestions for how to treat or prevent it.
Disease forecasting models typically rely on a single data stream, making models brittle when histories are short or noisy. Recent top-performing models have shown that synthesizing multiple reporting systems for the same disease improves performance. Other recent work takes this idea a step further, using transfer learning to train a forecasting model for one disease using data from a different disease. We expand upon each of these approaches greatly, training machine learning models on data that span 66 infectious diseases and several data streams. We investigate the value of incorporating different data streams for forecasting 20 different disease data streams. We find that incorporating other data streams improves forecasting in the vast majority (84.9%) of time series and model structures considered. However, our work highlights that the quality of the added data matters, where adding data extremely different from the target data stream can sometimes degrade forecast performance. A major contribution of this work is in compiling a publicly-available database of data for use by the infectious disease forecasting community.
This study addresses a critical gap in the healthcare system by developing a clinically meaningful, practical, and explainable disease surveillance system for multiple chronic diseases, utilizing routine EHR data from multiple U.S. practices integrated with CureMD's EMR/EHR system. Unlike traditional systems--using AI models that rely on features from patients' labs--our approach focuses on routinely available data, such as medical history, vitals, diagnoses, and medications, to preemptively assess the risks of chronic diseases in the next year. We trained three distinct models for each chronic disease: prediction models that forecast the risk of a disease 3, 6, and 12 months before a potential diagnosis. We developed Random Forest models, which were internally validated using F1 scores and AUROC as performance metrics and further evaluated by a panel of expert physicians for clinical relevance based on inferences grounded in medical knowledge. Additionally, we discuss our implementation of integrating these models into a practical EMR system. Beyond using Shapley attributes and surrogate models for explainability, we also introduce a new rule-engineering framework to enhance the i
The rapidly increasing volume of electronic health record (EHR) data underscores a pressing need to unlock biomedical knowledge from unstructured clinical texts to support advancements in data-driven clinical systems, including patient diagnosis, disease progression monitoring, treatment effects assessment, prediction of future clinical events, etc. While contextualized language models have demonstrated impressive performance improvements for named entity recognition (NER) systems in English corpora, there remains a scarcity of research focused on clinical texts in low-resource languages. To bridge this gap, our study aims to develop multiple deep contextual embedding models to enhance clinical NER in the cardiology domain, as part of the BioASQ MultiCardioNER shared task. We explore the effectiveness of different monolingual and multilingual BERT-based models, trained on general domain text, for extracting disease and medication mentions from clinical case reports written in English, Spanish, and Italian. We achieved an F1-score of 77.88% on Spanish Diseases Recognition (SDR), 92.09% on Spanish Medications Recognition (SMR), 91.74% on English Medications Recognition (EMR), and 88.
Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA sequencing, development of new computational and experimental approaches to prioritize genes and genetic variants, and increased global exchange of clinical and genetic data. However, more than half of individuals suspected to have a rare disease lack a genetic diagnosis. The Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium was initiated to study thousands of challenging rare disease cases and families and apply, standardize, and evaluate emerging genomics technologies and analytics to accelerate their adoption in clinical practice. Further, all data generated, currently representing ~7500 individuals from ~3000 families, is rapidly made available to researchers worldwide via the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) to catalyze global efforts to develop approaches for genetic diagnoses in rare diseases (https://gregorconsortium.org/data). The majority of these families have undergone prior clinical genetic testing
The main aim to build models capable of simulating the spreading of infectious diseases is to control them. And along this way, the key to find the optimal strategy for disease control is to obtain a large number of simulations of disease transitions under different scenarios. Therefore, the models that can simulate the spreading of diseases under scenarios closer to the reality and are with high efficiency are preferred. In the realistic social networks, the random contact, including contacts between people in the public places and the public transits, becomes the important access for the spreading of infectious diseases. In this paper, a model can efficiently simulate the spreading of infectious diseases under random contacts is proposed. In this approach, the random contact between people is characterized by the random matrix with elements randomly generated and the spread of the diseases is simulated by the Markov process. We report an interesting property of the proposed model: the main indicators of the spreading of the diseases such as the death rate are invariant of the size of the population. Therefore, representative simulations can be conducted on models consist of small
Heart disease is a serious worldwide health issue because it claims the lives of many people who might have been treated if the disease had been identified earlier. The leading cause of death in the world is cardiovascular disease, usually referred to as heart disease. Creating reliable, effective, and precise predictions for these diseases is one of the biggest issues facing the medical world today. Although there are tools for predicting heart diseases, they are either expensive or challenging to apply for determining a patient's risk. The best classifier for foretelling and spotting heart disease was the aim of this research. This experiment examined a range of machine learning approaches, including Logistic Regression, K-Nearest Neighbor, Support Vector Machine, and Artificial Neural Networks, to determine which machine learning algorithm was most effective at predicting heart diseases. One of the most often utilized data sets for this purpose, the UCI heart disease repository provided the data set for this study. The K-Nearest Neighbor technique was shown to be the most effective machine learning algorithm for determining whether a patient has heart disease. It will be benefic
In this work we present a deep learning approach to conduct hypothesis-free, transcriptomics-based matching of drugs for diseases. Our proposed neural network architecture is trained on approved drug-disease indications, taking as input the relevant disease and drug differential gene expression profiles, and learns to identify novel indications. We assemble an evaluation dataset of disease-drug indications spanning 68 diseases and evaluate in silico our approach against the most widely used transcriptomics-based matching baselines, CMap and the Characteristic Direction. Our results show a more than 200% improvement over both baselines in terms of standard retrieval metrics. We further showcase our model's ability to capture different genes' expressions interactions among drugs and diseases. We provide our trained models, data and code to predict with them at https://github.com/healx/dgem-nn-public.
Prion diseases are invariably fatal and highly infectious neurodegenerative diseases affecting humans and animals. By now there have not been some effective therapeutic approaches to treat all these prion diseases. In 2008, canine mammals including dogs (canis familials) were the first time academically reported to be resistant to prion diseases (Vaccine 26: 2601--2614 (2008)). Rabbits are the mammalian species known to be resistant to infection from prion diseases from other species (Journal of Virology 77: 2003--2009 (2003)). Horses were reported to be resistant to prion diseases too (Proceedings of the National Academy of Sciences USA 107: 19808--19813 (2010)). By now all the NMR structures of dog, rabbit and horse prion proteins had been released into protein data bank respectively in 2005, 2007 and 2010 (Proceedings of the National Academy of Sciences USA 102: 640--645 (2005), Journal of Biomolecular NMR 38:181 (2007), Journal of Molecular Biology 400: 121--128 (2010)). Thus, at this moment it is very worth studying the NMR molecular structures of horse, dog and rabbit prion proteins to obtain insights into their immunity prion diseases. This article reports the findings of th
Despite significant progress in dissecting the genetic architecture of complex diseases by genome-wide association studies (GWAS), the signals identified by association analysis may not have specific pathological relevance to diseases so that a large fraction of disease causing genetic variants is still hidden. Association is used to measure dependence between two variables or two sets of variables. Genome-wide association studies test association between a disease and SNPs (or other genetic variants) across the genome. Association analysis may detect superficial patterns between disease and genetic variants. Association signals provide limited information on the causal mechanism of diseases. The use of association analysis as a major analytical platform for genetic studies of complex diseases is a key issue that hampers discovery of the mechanism of diseases, calling into question the ability of GWAS to identify loci underlying diseases. It is time to move beyond association analysis toward techniques enabling the discovery of the underlying causal genetic strctures of complex diseases. To achieve this, we propose a concept of a genome-wide causation studies (GWCS) as an alternati
We examine a probabilistic model for the diagnosis of multiple diseases. In the model, diseases and findings are represented as binary variables. Also, diseases are marginally independent, features are conditionally independent given disease instances, and diseases interact to produce findings via a noisy OR-gate. An algorithm for computing the posterior probability of each disease, given a set of observed findings, called quickscore, is presented. The time complexity of the algorithm is O(nm-2m+), where n is the number of diseases, m+ is the number of positive findings and m- is the number of negative findings. Although the time complexity of quickscore i5 exponential in the number of positive findings, the algorithm is useful in practice because the number of observed positive findings is usually far less than the number of diseases under consideration. Performance results for quickscore applied to a probabilistic version of Quick Medical Reference (QMR) are provided.
Livestock mobility, particularly that of small and large ruminants, is one of the main pillars of production and trade in West Africa: livestock is moved around in search of better grazing or sold in markets for domestic consumption and for festival-related activities. These movements cover several thousand kilometers and have the capability of connecting the whole West African region thus facilitating the diffusion of many animal and zoonotic diseases. Several factors shape mobility patterns even in normal years and surveillance systems need to account for such changes. In this paper, we present a procedure based on temporal network theory to identify possible sentinel locations using two indicators: vulnerability (i.e. the probability of being reached by the disease) and time of infection (i.e. the time of first arrival of the disease). Using these indicators in our structural analysis of the changing network enabled us to identify a set of nodes that could be used in an early warning system. As a case study we simulated the introduction of F.A.S.T. (Foot and Mouth Similar Transboundary) diseases in Senegal and used data taken from 2020 Sanitary certificates (LPS, laissez-passer
Is cancer a disease that can be cured or a degenerative disease which comes predominantly with old age? We give an answer based on a two-dimensional representation of diseases. These two dimensions are defined as follows. In mortality curves there is an age, namely a_c = 10 years, which plays a crucial role in the sense that the mortality rate decreases in the interval I1=(a<a_c) and increases in the interval I2=(a>a_c). The respective trends in I1 and I2 are the two parameters used in our classification of diseases. Within the framework of reliability analysis, I1 and I2 would be referred to as the "burn-in" and "wear-out" phases. This leads to define three broad groups of diseases. (AS1) Asymmetry with prevalence of I1. (AS2) Asymmetry with prevalence of I2. (S) Symmetry, with I1 and I2 both playing roles of comparable importance. Not surprisingly, among AS1-cases one finds all diseases due to congenital malformations. In the AS2-class one finds degenerative diseases, e.g. Alzheimer's disease. Among S-cases one finds most diseases due to external pathogens or to wear-out processes. Cancer is one of those mixed cases and it is closer to (AS2) than to (AS1). This representati
We systematically evaluate the performance of deep learning models in the presence of diseases not labeled for or present during training. First, we evaluate whether deep learning models trained on a subset of diseases (seen diseases) can detect the presence of any one of a larger set of diseases. We find that models tend to falsely classify diseases outside of the subset (unseen diseases) as "no disease". Second, we evaluate whether models trained on seen diseases can detect seen diseases when co-occurring with diseases outside the subset (unseen diseases). We find that models are still able to detect seen diseases even when co-occurring with unseen diseases. Third, we evaluate whether feature representations learned by models may be used to detect the presence of unseen diseases given a small labeled set of unseen diseases. We find that the penultimate layer of the deep neural network provides useful features for unseen disease detection. Our results can inform the safe clinical deployment of deep learning models trained on a non-exhaustive set of disease classes.
Increased access to reliable health information is essential for non-English-speaking populations, yet resources in Bangla for disease prediction remain limited. This study addresses this gap by developing a comprehensive Bangla symptoms-disease dataset containing 758 unique symptom-disease relationships spanning 85 diseases. To ensure transparency and reproducibility, we also make our dataset publicly available. The dataset enables the prediction of diseases based on Bangla symptom inputs, supporting healthcare accessibility for Bengali-speaking populations. Using this dataset, we evaluated multiple machine learning models to predict diseases based on symptoms provided in Bangla and analyzed their performance on our dataset. Both soft and hard voting ensemble approaches combining top-performing models achieved 98\% accuracy, demonstrating superior robustness and generalization. Our work establishes a foundational resource for disease prediction in Bangla, paving the way for future advancements in localized health informatics and diagnostic tools. This contribution aims to enhance equitable access to health information for Bangla-speaking communities, particularly for early disease
Accurate disease detection is of paramount importance for effective medical treatment and patient care. However, the process of disease detection is often associated with extensive medical testing and considerable costs, making it impractical to perform all possible medical tests on a patient to diagnose or predict hundreds or thousands of diseases. In this work, we propose Collaborative Learning for Disease Detection (CLDD), a novel graph-based deep learning model that formulates disease detection as a collaborative learning task by exploiting associations among diseases and similarities among patients adaptively. CLDD integrates patient-disease interactions and demographic features from electronic health records to detect hundreds or thousands of diseases for every patient, with little to no reliance on the corresponding medical tests. Extensive experiments on a processed version of the MIMIC-IV dataset comprising 61,191 patients and 2,000 diseases demonstrate that CLDD consistently outperforms representative baselines across multiple metrics, achieving a 6.33\% improvement in recall and 7.63\% improvement in precision. Furthermore, case studies on individual patients illustrate